Genetics and Genomics

Science News

Use of Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing
Cardiomyopathy in Children Classification and Diagnosis
Establishment of Specialized Clinical Cardiovascular Genetics Programs Recognizing Standards
2019 CVD Primary Prevention Guideline
Animal Models of Hypertension

Continuing Education

Registration Now Open

Mark your calendars now to experience the premier global event focusing on improving health by championing scientific discovery and practice-changing educational content.

We can't wait to see you this November! Even though #AHA21 was fully virtual, our flagship meeting brought us together across the globe. If you missed some of our great programming, now is your chance!

Members can now access informative, practice-changing sessions or earn CE credits for free through a different link. And nonmembers can still purchase our Sessions package or our special CE bundle.

The GPM Council seeks to advance discovery and translation of biological insights from genetics and omics technologies to improve cardiovascular and brain health through better risk prediction, treatment and prevention for patients. Our expertise spans genetics, genomics, genomic medicine, epigenetics, transcriptomics, metabolomics, proteomics, microbiome, bioinformatics, computational science, and population health.


Since 1999, the BCVS Council has advanced understanding of mechanisms of basic cardiovascular regulation to support insights into cardiovascular disease and facilitate new therapies. Emphasis is on integrating molecular/cellular and physiological approaches to address problems relating to genomics, cell signaling, myocardial biology, circulatory physiology, pathophysiology, and peripheral vascular disease.


The ATVB Council focuses on arteriosclerosis, thrombosis and vascular biology. The council advances research, addresses prevention, improves diagnosis and treatment, and works actively with other organizations. It shares reliable information through its annual conference, awards and lectures, and in the AHA’s journal, Arteriosclerosis, Thrombosis, and Vascular Biology.


CRAVE Results

Gregory M. Marcus, MD, MAS explains the methodology and results of the CRAVE trial, designed to assess the acute affects of coffee consumption in ambulatory patients.

American Heart Association Professional Members

Enjoy instant benefits!

  • Free Online Access to AHA Scientific Journals
  • Affiliate with our 16 Scientific Councils
  • Discounts on Scientific Conference Registration and Online Courses